HC Wainwright & Co. : The Capricorn Therapeutics (CAPR.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $40.00.
Zhitong FinanceApr 25 19:30
Capricor Therapeutics Analyst Ratings
BenzingaApr 25 19:24
Optimistic Outlook for Capricor Therapeutics: Buy Rating Affirmed Amid Regulatory Progress and Strong Financial Position
TipRanksApr 25 18:25
Capricor Therapeutics: Strong Buy Rating Backed by Robust Financials and Promising Clinical Progress
TipRanksMar 6 01:55
HC Wainwright & Co. Reiterates Buy on Capricor Therapeutics, Maintains $40 Price Target
BenzingaMar 1 19:51
Capricor Therapeutics Analyst Ratings
BenzingaMar 1 19:49
Analysts' Opinions Are Mixed on These Healthcare Stocks: Keros Therapeutics (KROS), Veeva Systems (VEEV) and Capricor Therapeutics (CAPR)
TipRanksMar 1 19:20
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), CVRx (CVRX) and Capricor Therapeutics (CAPR)
TipRanksJan 26 20:41
Cantor Fitzgerald Initiates Coverage On Capricor Therapeutics With Overweight Rating, Announces Price Target of $8
BenzingaJan 5 23:31
Capricor Therapeutics Analyst Ratings
BenzingaJan 5 23:29
Capricor Therapeutics: Solid Financials and Promising DMD Trial Progression Support Buy Rating
TipRanksNov 17, 2023 02:55
Capricor Therapeutics Exceeds Expectations: Promising Financial Results and Operational Developments Lead to Buy Rating
TipRanksNov 15, 2023 19:16
Analysts Conflicted on These Healthcare Names: Replimune Group (REPL), Capricor Therapeutics (CAPR) and Intellia Therapeutics (NTLA)
TipRanksOct 4, 2023 18:31
HC Wainwright & Co. Maintains Buy on Capricor Therapeutics, Raises Price Target to $40
BenzingaOct 4, 2023 18:14
Capricor Therapeutics Analyst Ratings
BenzingaOct 4, 2023 18:13
Analysts Offer Insights on Healthcare Companies: Advanced Human Imaging (AHI) and Capricor Therapeutics (CAPR)
TipRanksOct 3, 2023 19:40
Capricor Therapeutics Analyst Ratings
BenzingaAug 15, 2023 18:35
H.C. Wainwright Sticks to Its Buy Rating for Capricor Therapeutics (CAPR)
TipRanksAug 15, 2023 18:25
Maxim Group Keeps Their Buy Rating on Capricor Therapeutics (CAPR)
TipRanksAug 9, 2023 19:45
Maxim Group Keeps Their Buy Rating on Capricor Therapeutics (CAPR)
TipRanksMay 13, 2023 21:05
No Data
No Data